AC
Alan Carr Needham Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $170 |
210%
upside
| Buy | 4 years ago |
|
2
Vir Biotechnology
VIR
$732M
| $5.27 | $62 |
1,076%
upside
| Buy | 5 years ago |
|
3
Vaxcyte
PCVX
$4.29B
| $33.02 | $40 |
21%
upside
| Buy | 5 years ago |
|
4
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $160 |
65%
downside
| Buy | 5 years ago |
|
5
Cidara Therapeutics
CDTX
$1.6B
| $63.17 | $120 |
90%
upside
| Buy | 5 years ago |
|